Eye Therapies, LLC v. Slayback Pharma LLC
CAFC Affirms Non-Infringement of Ophthalmic Drug Patent
Federal Circuit · 2025-06-30 · Defendant Win · Impact: 25/100
Eye Therapies, LLC v. Slayback Pharma LLC, decided by Federal Circuit on June 30, 2025, resulted in a defendant win outcome. The core dispute centered on whether Slayback Pharma LLC's proposed generic...